Log In
Print this Print this

Actimab-C, Actinium-C

  Manage Alerts
Collapse Summary General Information
Company Actinium Pharmaceuticals Inc.
DescriptionNot disclosed
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationColorectal cancer
Indication DetailsTreat colorectal cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today